Gyermekkori daganatok: vizsgálatok itt: Németország
144 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Berlin
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Dresden, Frankfurt Am Main, Halle (Saale), Heidelberg, Munich, Ulm
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 3. fázisTaking peopleInternational study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Datteln, Dortmund, Dresden, Düsseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Göttingen, Halle (Saale), Hamburg, Hanover, Heidelberg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Lübeck, Magdeburg, Mainz, Mannheim, Minden, Munich, Münster, Nürnberg, Oldenburg, Ratisbon, Rostock, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 17 év
- People
- 137 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501454-11-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Brunswick, Chemnitz, Duesseldorf, Hamburg, Heidelberg, Herne, Jena, Leipzig, Minden, Stuttgart, Tuebingen
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 1. fázisNot yet taking people in NémetországA Study of Mirdametinib in Infants and Toddlers With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas
- Where
- Cologne, Hamburg
- Életkor
- 0 hónap to 21 hónap
- People
- 6 worldwide
- Run by
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT07850635 · EU 2025-522000-24-00 - 3. fázisNot yet taking people in NémetországComparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Cologne, Dortmund, Duesseldorf, Duisburg, Erfurt, Erlangen, Essen, Freiburg im Breisgau, Goettingen, Halle (Saale), Hamburg, Hanover, Heidelberg, Karlsruhe, Kassel, Kiel, Krefeld, Leipzig, Luebeck, Mainz, Minden, Regensburg, Rostock, Stuttgart, Tuebingen, Ulm
- Életkor
- Up to 5 év
- People
- 96 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT07291102 · EU 2024-517133-40-00 - 2/3. fázisTaking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Frankfurt
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisTaking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Gießen, Goettingen, Greifswald, Halle Saale, Hamburg, Hanover, Heidelberg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Lübeck, Magdeburg, Mainz, Mannheim, Minden, Muenster, München, Munich, Nuremberg, Nürnberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 64 év
- People
- 1351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Aachen, Augsburg, Berlin, Bonn, Bremen, Cologne, Dortmund, Dresden, Duesseldorf, Erlangen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Halle Saale, Hamburg, Hanover, Heidelberg, Kiel, Krefeld, Mainz, Muenster, Munich, Stuttgart, Tuebingen, Ulm
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 3. fázisNot yet taking people in NémetországProspective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Cologne, Dortmund, Dresden, Erfurt, Erlangen, Giessen, Goettingen, Halle (Saale), Jena, Karlsruhe, Kassel, Krefeld, Leipzig, Magdeburg, Mainz, Mannheim, Muenster, Regensburg, Sankt Augustin, Stuttgart, Wuerzburg
- Életkor
- Up to 64 év
- People
- 231
- Run by
- University Of Cologne
See details and how to join2024-517295-37-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Berlin, Cologne, Duesseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Kiel, Muenster, Munich, Wuerzburg
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Berlin, Cologne, Erlangen, Würzburg
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Hamburg, Leipzig, Mainz, Ulm
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1/2. fázisTaking peopleLong-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
- Where
- Berlin, Cologne, Erlangen, Goettingen, Muenster, Munich, Tuebingen, Wuerzburg
- People
- 40
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508775 · EU 2022-501648-14-00 - 1/2. fázisNot yet taking people in NémetországStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Berlin, Cologne, Erlangen, Essen, Frankfurt Am Main, Hamburg
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Berlin, Buxtehude, Dresden, Erfurt, Erlangen, Gera, Halle (Saale), Hamburg, Kiel, Leipzig, Ludwigshafen Am Rhein, Luebeck, Magdeburg, Mainz, Mannheim, Marburg, Minden, Muenster, Nuremberg, Tuebingen, Wuerzburg
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 1/2. fázisTaking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Berlin, Cologne, Giessen, Muenster, Tuebingen
- Életkor
- 1 hónap to 17 év
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Augsburg, Essen, Frankfurt am Main, Hamburg, Heidelberg
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - No phaseTaking peopleA Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Where
- Freiburg im Breisgau
- People
- 170 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06423573 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Cologne
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Berlin, Duesseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Hamburg, Hanover, Jena, Kiel, Muenster, Tuebingen, Ulm, Wuerzburg
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 1. fázisTaking peopleLong-term follow-up of patients treated with GD2IL18CART
- Where
- Erlangen, Essen, Muenster, Tuebingen
- People
- 20
- Run by
- Universitaet Muenster
See details and how to join2025-521497-34-00 - 2. fázisTaking peopleLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Dresden, Hamburg, Heidelberg, Mainz, Munich, Wuerzburg
- People
- 1500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - 3. fázisTaking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Aachen, Augsburg, Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Frankfurt Am Main, Gießen, Göttingen, Halle Saale, Hamburg, Hanover, Heidelberg, Jena, Kassel, Kiel, Leipzig, Magdeburg, Mainz, Muenster, Munich, Ratisbon, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 17 év
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 - 3. fázisNot yet taking people in NémetországAIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
- Where
- Aachen, Augsburg, Berlin, Brunswick, Chemnitz, Cologne, Cottbus, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luebeck, Magdeburg, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Witten, Wolfsburg, Wuerzburg
- Életkor
- Up to 17 év
- People
- 2250
- Run by
- Universitaetsklinikum Schleswig-Holstein AöR
See details and how to join2025-522190-11-01